Loading...
Loading...
Indian Pharmaceutical Exporter Β· #11 for Piperacillin Β· $755.1K export value Β· DGFT Verified
Stallion Laboratories Pvt Ltd is the #11 Indian exporter of Piperacillin with $755.1K in export value and 87 verified shipments. Stallion Laboratories Pvt Ltd holds a 0.9% market share in Piperacillin exports across 1 countries.

| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $11.7M | 233 | 25.4% |
| PHILIPPINES | $9.1M | 412 | 19.9% |
| BRAZIL | $7.5M | 150 | 16.4% |
| MALAYSIA | $3.0M | 60 | 6.5% |
| THAILAND | $2.5M | 51 | 5.6% |
| MALTA | $2.5M | 49 | 5.3% |
| HONG KONG | $2.3M | 46 | 5.0% |
| CANADA | $1.5M | 30 | 3.3% |
| UNITED KINGDOM | $1.3M | 28 | 2.8% |
| COLOMBIA | $1.0M | 20 | 2.2% |
India exports Piperacillin to 111 countries. The top destination is UNITED STATES (25.4%), followed by PHILIPPINES and BRAZIL.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MYLAN BRASIL DISTRIBUIDORA DE | BRAZIL | $3.9M | 77 |
| EUGIA US LLC | UNITED STATES | $3.8M | 76 |
| ARMAS PHARMACEUTICALS | UNITED STATES | $3.2M | 64 |
| HONG LEONG BANK BERHAD | MALAYSIA | $1.6M | 33 |
| VIATRIS BRASIL IMPORTADORA E DISTRI | BRAZIL |
India exported $43.4M worth of Piperacillin through 2,138 shipments from 280 suppliers to 111 countries, serving 529 buyers globally. Stallion Laboratories Pvt Ltd contributes $755.1K to this total, accounting for 0.9% of India's Piperacillin exports.
Stallion Laboratories Pvt Ltd's average Piperacillin shipment value is $8.7K per consignment, based on 87 shipments totaling $755.1K.
Stallion Laboratories Pvt Ltd ranks #11 among 280 Indian Piperacillin exporters with a 0.9% market share. The top 3 exporters are AUROBINDO PHARMA LTD ($13.8M), STERISCIENCE SPECIALTIES PRIVATE LIMITED ($9.8M), AUROBINDO PHARMA LIMITED ($5.0M). Stallion Laboratories Pvt Ltd processed 87 shipments to 1 destination countries.
What Stallion Laboratories Pvt Ltd must comply with to export Piperacillin to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10β18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Approval Process
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | SWISS PARENTERALS LIMITED | $1.0M | 21 | 9 | $49.6K |
| 10 | ACULIFE HEALTHCARE PRIVATE LIMITED | $867.2K | 18 | 5 | $48.2K |
| 11 | STALLION LABORATORIES PVT LTD β | $755.1K | 87 | 1 | $8.7K |
| 12 | VENUS REMEDIES LIMITED | $730.8K |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 193 | 9.0% |
| SAHAR AIR | 187 | 8.7% |
| NHAVA SHEVA SEA (INNSA1) | 127 | 5.9% |
| HYDERABAD ICD (INSNF6) | 108 | 5.1% |
| HYDERABAD AIR | 103 | 4.8% |
| DELHI AIR | 94 | 4.4% |
| BANGALORE ICD (INWFD6) | 91 | 4.3% |
| HYDERABAD ACC (INHYD4) | 90 | 4.2% |
Latest developments and market context
Detailed market intelligence for Piperacillin β including regulatory updates, trade policy changes, and competitive landscape analysis β will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records β the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Stallion Laboratories Pvt Ltd's Piperacillin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
| $1.5M |
| 30 |
| AUROLOGISTICS LLC (AUROMEDICS PHARM | UNITED STATES | $1.0M | 20 |
| EUGIA PHARMA (MALTA) LTD | MALTA | $800.0K | 16 |
| ANTIBIOTICOS DO BRASIL LTDA | BRAZIL | $650.0K | 13 |
| XXGIAXXS LXX | UNITED STATES | $650.0K | 13 |
| CARDINAL HEALTH LAVERGNE III | UNITED STATES | $350.0K | 7 |
India's Piperacillin is purchased by 529 buyers worldwide. The top buyer is MYLAN BRASIL DISTRIBUIDORA DE (BRAZIL), followed by EUGIA US LLC and ARMAS PHARMACEUTICALS.
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12β24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
| 37 |
| 13 |
| $19.8K |
| 14 | INJECT CARE PARENTERALS PRIVATE LIMITED | $510.9K | 21 | 9 | $24.3K |
Stallion Laboratories Pvt Ltd ranks #11 among 280 Indian Piperacillin exporters. Average shipment value of $8.7K compared to the market average of $155.1K. The closest competitors by value are SWISS PARENTERALS LIMITED and ACULIFE HEALTHCARE PRIVATE LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 111+ countries, 529+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Stallion Laboratories Pvt Ltd.
Request DemoView Pricing βTrade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Piperacillin. For current shipment-level data, contact TransData Nexus.